High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011
12-Jul-2007
"Today's decision is yet another affirmation of the strength of the intellectual property behind Lipitor," said Pfizer General Counsel Allen Waxman. "It also is an important outcome for Pfizer and other medical innovators who invest in high-risk research to develop life-saving medicines, and for the patients who benefit from those medicines."
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.